Plasma platelet-derived microparticles in patients with connective tissue diseases.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 21239749.
- Also identified by DOI 10.3899/jrheum.100780.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To clarify the role of platelet-derived microparticles (PDMP), which are small vesicles with thrombotic and immunological properties, in systemic lupus erythematosus (SLE), systemic sclerosis (SSc), dermatomyositis/polymyositis (PM/DM), and mixed connective tissue disease (MCTD). Plasma levels of PDMP were measured by ELISA, and compared among patients with one of the 4 diseases. Association of PDMP levels with clinical characteristics and medication of the patients was also examined. PDMP levels were higher in patients with MCTD and SSc than in controls. Multiple linear regression analysis revealed that patients with Raynaud's phenomenon (RP) showed higher PDMP levels than those without. PDMP levels in individual patients did not fluctuate significantly over several months. PDMP level is associated with MCTD, SSc, and RP, and could be a novel marker for RP.
Medical subject headings
- Blood Platelets
- Cell-Derived Microparticles
- Connective Tissue Diseases